Reduction in the free radical status and clinical benefit of repeated intrathecal triamcinolone acetonide application in patients with progressive multiple sclerosis.
Müller T, Herrling T, Lütge S, Küchler M, Lohse L, Rothe H, Haas T, Marg M, Ohm G, Jung K